IL13 and Alzheimer disease: However, treatment of keratinocytes with IL‐13 resulted in a weak negative correlation, perhaps due to significant lesional keratinocyte upregulation of the non‐functional IL‐13 decoy receptor IL13RA2 (Figure S1C), which is overexpressed in lichenified lesional AD skin.35